CVS Health revenues up 18%; Non-GAAP EPS up 8% in Q2; revises FY16 guidance

• CVS Health (NYSE:CVS +3.8%) Q2 results: Revenues: $43,725M (+17.6%); Operating Income: $2,350M (+3.9%); Net Income: $924M (-27.4%); EPS: $0.86 (-23.2%); Non-GAAP EPS: $1.32 (+8.2%); Quick Assets: $1,207M (-52.6%); CF Ops: $4023M (+33.2%).
• Q3 Guidance: GAAP EPS: $1.38 - 1.41; Adjusted EPS: $1.55 - 1.58.
• 2016 Guidance: GAAP EPS: $4.92 - 5.00 from $5.24 - 5.39; Adjusted EPS: $5.81 - 5.89 from $5.73 - 5.88; CF Ops: $8.8B - 9.1B from $7.6B - 7.9B; FCF: $6.3B - 6.6B from $5.3B - 5.6B.